# A Phase III Multi Regional Clinical Trial (MRCT) of Tricaprilin in Mild to Moderately Severe Probable Alzheimer's Disease With Optional Open Label Extension

> **NCT04187547** · PHASE3 · WITHDRAWN · sponsor: **Cerecin**

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** Tricaprilin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04187547
- **Lead sponsor:** Cerecin
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-06-30
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-02-28
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study replaced with a new study
- **Last updated:** 2023-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04187547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04187547, "A Phase III Multi Regional Clinical Trial (MRCT) of Tricaprilin in Mild to Moderately Severe Probable Alzheimer's Disease With Optional Open Label Extension". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04187547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*